Suchergebnisse - "Rahman, Omar"

PubPharm (7)

1

Smoking and EGFR status may predict outcomes of advanced NSCLC treated with PD-(L)1 inhibitors beyond first line : A meta-analysis

enthalten in: The clinical respiratory journal | 2018

von Abdel-Rahman, O.

2

Evaluation of efficacy and safety of different pembrolizumab dose/schedules in treatment of non-small-cell lung cancer and melanoma : a systematic review

enthalten in: Immunotherapy | 2016

von Abdel-Rahman, O.

ErratumIn: Immunotherapy. 2017 Mar;9(4):373. - PMID 28303770

3

Risk of endocrine complications in cancer patients treated with immune check point inhibitors : a meta-analysis

enthalten in: Future oncology (London, England) | 2016

von Abdel-Rahman, O. | ElHalawani, H. | Fouad, M.

4

Risk of oral and gastrointestinal mucosal injury in patients with solid tumors treated with ramucirumab : a systematic review and meta-analysis

enthalten in: Expert opinion on drug safety | 2015

von Abdel-Rahman, O. | ElHalawani, H.

5

Correlation of cetuximab-induced skin rash and outcomes of solid tumor patients treated with cetuximab : a systematic review and meta-analysis

enthalten in: Critical reviews in oncology/hematology | 2015

von Abdel-Rahman, O. | Fouad, M.

6

Risk of hematological toxicities in patients with solid tumors treated with ramucirumab : a meta-analysis

enthalten in: Future oncology (London, England) | 2015

von Abdel-Rahman, O. | ElHalawani, H.

7

Proteinuria in Patients with Solid Tumors Treated with Ramucirumab : A Systematic Review and Meta-Analysis

enthalten in: Chemotherapy | 2014

von Abdel-Rahman, O. | ElHalawani, H.

1
[1]